The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood-based-inflammation-markers, body mass index, and survival of nonmetastatic esophageal cancer.
 
Wanning Wang
No Relationships to Disclose
 
Joelle Soriano
No Relationships to Disclose
 
Tyler Soberano
No Relationships to Disclose
 
Katrina Hueniken
No Relationships to Disclose
 
M. Catherine Brown
No Relationships to Disclose
 
Kirsty Taylor
No Relationships to Disclose
 
Jaspreet K. Bajwa
No Relationships to Disclose
 
George Dong
No Relationships to Disclose
 
Eric Xueyu Chen
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Raymond Woo-Jun Jang
Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
 
Rebecca Wong
No Relationships to Disclose
 
Gail Elizabeth Darling
No Relationships to Disclose
 
Wei Xu
No Relationships to Disclose
 
Micheal McInnis
Honoraria - Bayer; Bayer; Bayer; Bayer
 
Geoffrey Liu
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Merck; Merck; novartis; novartis; novartis; novartis; pfizer; pfizer; pfizer; pfizer; Roche Canada; Roche Canada; Roche Canada; Roche Canada; Takeda; Takeda; Takeda; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; novartis; novartis; novartis; novartis; pfizer; pfizer; pfizer; pfizer; Roche Canada; Roche Canada; Roche Canada; Roche Canada; takeda; takeda; takeda; takeda
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - roche (Inst); roche (Inst); roche (Inst); roche (Inst)
 
Dmitry Rozenberg
No Relationships to Disclose
 
Elena Elimova
Employment - Merck (I); Merck (I); Merck (I); Merck (I)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Aline Fusco Fares
No Relationships to Disclose